# Humalog or Humulin for Intensive Insulin Therapy in Intensive Care Unit

> **NCT02165566** · PHASE4 · COMPLETED · sponsor: **University of Roma La Sapienza** · enrollment: 28 (actual)

## Conditions studied

- Hyperglycemia

## Interventions

- **DRUG:** Regular-insulin
- **DRUG:** Lispro-insulin

## Key facts

- **NCT ID:** NCT02165566
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2014-03
- **Final completion:** 2014-05
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2014-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02165566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02165566, "Humalog or Humulin for Intensive Insulin Therapy in Intensive Care Unit". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02165566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*